Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme.

MLA

Biava, Mariangela, et al. “Improving the Solubility of a New Class of Antiinflammatory Pharmacodynamic Hybrids, That Release Nitric Oxide and Inhibit Cycloxygenase-2 Isoenzyme.” European Journal of Medicinal Chemistry, vol. 58, Dec. 2012, pp. 287–98. EBSCOhost, https://doi.org/10.1016/j.ejmech.2012.10.014.

APA

Biava, M., Battilocchio, C., Poce, G., Alfonso, S., Consalvi, S., Porretta, G. C., Schenone, S., Calderone, V., Martelli, A., Testai, L., Ghelardini, C., Di Cesare Mannelli, L., Sautebin, L., Rossi, A., Giordani, A., Patrignani, P., & Anzini, M. (2012). Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme. European Journal of Medicinal Chemistry, 58, 287–298. https://doi.org/10.1016/j.ejmech.2012.10.014

Chicago

Biava, Mariangela, Claudio Battilocchio, Giovanna Poce, Salvatore Alfonso, Sara Consalvi, Giulio Cesare Porretta, Silvia Schenone, et al. 2012. “Improving the Solubility of a New Class of Antiinflammatory Pharmacodynamic Hybrids, That Release Nitric Oxide and Inhibit Cycloxygenase-2 Isoenzyme.” European Journal of Medicinal Chemistry 58 (December): 287–98. doi:10.1016/j.ejmech.2012.10.014.